# RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia

> **NCT01132456** · NA · COMPLETED · sponsor: **Medtronic Vascular** · enrollment: 312 (actual)

## Conditions studied

- Ischemic Heart Disease
- Coronary Stenosis
- Cardiovascular Diseases
- Arteriosclerosis
- Coronary Artery Disease

## Interventions

- **DEVICE:** Drug eluting stent treatment

## Key facts

- **NCT ID:** NCT01132456
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-05
- **Final completion:** 2016-04
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2016-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01132456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01132456, "RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01132456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*